<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39439787</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation.</ArticleTitle><Pagination><StartPage>1463769</StartPage><MedlinePgn>1463769</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1463769</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1463769</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Solid organ transplant (SOT) recipients display weak seroconversion and neutralizing antibody (NAb) responses after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and remain at risk of severe coronavirus disease 2019 (COVID-19). While B-cell memory is the hallmark of serological immunity, its role in driving successful vaccine responses and providing immune protection in SOT patients remains unclear.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We investigated the function and interplay of SARS-CoV-2-specific memory B cells (mBc), different cytokineproducing T cells, and cross-reactive NAb in driving seroconversion and protection against COVID-19 in two cohorts. First, we studied a large cohort of 148 SOT recipients and 32 immunocompetent individuals who underwent several vaccinations. Subsequently, we assessed 25 SOT patients participating in a randomized controlled trial to compare two different immunosuppressive strategies for allowing successful seroconversion and memory-cell responses after booster vaccination.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We corroborate previous findings that B- and T-cell memory responses are weaker and more delayed in SOT patients than in immunocompetent (IC) individuals; however, within the SOT cohort, we found that these responses are relatively stronger and more robust in patients not receiving mycophenolate mofetil (MMF)-based therapies. Anti- spike IgG titers strongly correlated with RBD-specific IgG-producing mBc, with both displaying broad viral cross reactivity. Prebooster SARS-CoV-2-specific mBc and IL-2- producing T cells accurately predicted Nab seroconversion (AUC, 0.828) and protection against severe COVID-19. While switching unresponsive SOT patients from calcineurin inhibitors (CNI)/MMF to a low-exposure CNI/mTOR-i regimen favored wider SARS-CoV-2-specific immune responses after a fourth booster vaccination, preformed RBD-specific mBc predicted NAb seroconversion.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Our study adds new insights into the pathobiology of immune memory and highlights the pivotal role of SARS-CoV-2-specific mBc in promoting immune protection inSOT patients.</AbstractText><CopyrightInformation>Copyright © 2024 Donadeu, Gomez-Olles, Casanova, Torija, Lopez-Meseguer, Boada-Pérez, Kervella, Crespo, Carrera-Muñoz, Campos-Varela, Castells, Cortese, Esperalba, Fernández-Naval, Quintero, Muñoz, Agüero, Gonzalez-Costello, Lladó, Favà, Cañas, del Mar de la Hoz-Caballero, Meneghini, Torres, Juvé, Hafkamp, Vila, Robles, Buzón, Toapanta, Zúñiga, Monforte, Saez-Giménez, Len, Arcos, Miret, Ariceta, Pardo, Martínez, Moreso and Bestard.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Donadeu</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez-Olles</LastName><ForeName>Susana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Pneumology, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casanova</LastName><ForeName>Franc</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torija</LastName><ForeName>Alba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Meseguer</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Pneumology, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ciber Enfermedades Respiratorias (CIBERES), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lung Transplant Unit, Pneumology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boada-Pérez</LastName><ForeName>Meritxell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Pneumology, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kervella</LastName><ForeName>Delphine</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crespo</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrera-Muñoz</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos-Varela</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liver Unit, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castells</LastName><ForeName>Lluís</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liver Unit, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortese</LastName><ForeName>Maria F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Microbiology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esperalba</LastName><ForeName>Juliana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernández-Naval</LastName><ForeName>Candela</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Microbiology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintero</LastName><ForeName>Jesús</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Hepatology and Liver Transplant Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muñoz</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agüero</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Epidemiology, Bellvitge University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Costello</LastName><ForeName>José</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Advanced Heart Failure and Heart Transplant Unit, Department of Cardiology, Hospital Universitari de Bellvitge, BIOHEART-Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), Universitat de Barcelona, Ciber Cardiovascular (CIBERCV), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lladó</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Liver Transplant Unit, Bellvitge University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Favà</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kidney Transplant Unit, Bellvitge University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cañas</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology department, Germans Trias i Pujol Hospital, Badalona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Mar de la Hoz-Caballero</LastName><ForeName>María</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Equipo de Atención Primaria Sant Rafael, Servei d'Atenció Primària (SAP) Muntanya, Gerència Territorial de Barcelona Ciutat, Institut Català de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meneghini</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Irina B</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juvé</LastName><ForeName>Mariona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafkamp</LastName><ForeName>Fmj</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vila</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Microbiology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robles</LastName><ForeName>Alba G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buzón</LastName><ForeName>Maria José</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toapanta</LastName><ForeName>Nestor</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zúñiga</LastName><ForeName>José Miguel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monforte</LastName><ForeName>Víctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Pneumology, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lung Transplant Unit, Pneumology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saez-Giménez</LastName><ForeName>Berta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Pneumology, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lung Transplant Unit, Pneumology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Len</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcos</LastName><ForeName>Ibai Los</ForeName><Initials>IL</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miret</LastName><ForeName>Enric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Urology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ariceta</LastName><ForeName>Gema</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pardo</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Epidemiology, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreso</LastName><ForeName>Francesc</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bestard</LastName><ForeName>Oriol</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Laboratory of Nephrology and Transplantation, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vall d'Hebron for Solid Organ Transplantation Research Group, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidney Transplant Unit, Nephrology Department, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091245" MajorTopicYN="Y">Memory B Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="Y">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016377" MajorTopicYN="Y">Organ Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007117" MajorTopicYN="Y">Immunization, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007156" MajorTopicYN="N">Immunologic Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069078" MajorTopicYN="N">Seroconversion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">adaptive immunity</Keyword><Keyword MajorTopicYN="N">booster vaccination</Keyword><Keyword MajorTopicYN="N">neutralizing antibodies</Keyword><Keyword MajorTopicYN="N">solid organ transplantation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39439787</ArticleId><ArticleId IdType="pmc">PMC11493670</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1463769</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. . BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. (2021) 384:1412–23. doi: 10.1056/NEJMoa2101765</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2101765</ArticleId><ArticleId IdType="pmc">PMC7944975</ArticleId><ArticleId IdType="pubmed">33626250</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinaki S, Xagas E, Tsoutsoura P, Katsaros D, Korogiannou M, Boletis IN. Occurrence of severe SARS-CoV-2 infection in fully vaccinated solid organ transplant recipients. Transplant Proc. (2022) 54:1405–8. doi: 10.1016/j.transproceed.2021.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transproceed.2021.12.012</ArticleId><ArticleId IdType="pmc">PMC8718957</ArticleId><ArticleId IdType="pubmed">35074163</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinaki S, Tsiakas S, Korogiannou M, Grigorakos K, Papalois V, Boletis I. A systematic review of COVID-19 infection in kidney transplant recipients: A universal effort to preserve patients’ Lives and allografts. J Clin Med. (2020) 9:2986. doi: 10.3390/jcm9092986</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092986</ArticleId><ArticleId IdType="pmc">PMC7563559</ArticleId><ArticleId IdType="pubmed">32947798</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control. Interim public health considerations for the provision of additional COVID-19 vaccine doses (2021). ECDC: Stockholm; (Accessed 1 September 2021).</Citation></Reference><Reference><Citation>Baden RL, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. . Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. (2021) 384:403–16. doi: 10.1056/NEJMoa2035389</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestard O, Jouve T, Castells Ll Lopez M, Muñoz M, Crespo E, et al. . Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients. Am J Transplant. (2021) 22:673–5. doi: 10.1111/ajt.16855</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16855</ArticleId><ArticleId IdType="pmc">PMC8653131</ArticleId><ArticleId IdType="pubmed">34554648</ArticleId></ArticleIdList></Reference><Reference><Citation>Miele M, Busà R, Russelli G, Concetta Sorrentino M, Di Bella M, Timoneri F, et al. . Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients. Am J Transplant. (2021) 21:2919–21. doi: 10.1111/ajt.16702</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16702</ArticleId><ArticleId IdType="pmc">PMC8222937</ArticleId><ArticleId IdType="pubmed">34058052</ArticleId></ArticleIdList></Reference><Reference><Citation>Caillard S, Chavarot N, Bertrand D, Kamar N, Thaunat O, Moal V, et al. . Occurrence of severe COVID-19 in vaccinated transplant patients. Kidney Int. (2021) 100:477–9. doi: 10.1016/j.kint.2021.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.05.011</ArticleId><ArticleId IdType="pmc">PMC8141267</ArticleId><ArticleId IdType="pubmed">34029554</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin CX, Moore LW, Anjan S, Rahamimov R, Sifri CD, Ali NM, et al. . Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. Transplantation. (2021) 105:e265–6. doi: 10.1097/TP.0000000000003907</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000003907</ArticleId><ArticleId IdType="pmc">PMC8549120</ArticleId><ArticleId IdType="pubmed">34310531</ArticleId></ArticleIdList></Reference><Reference><Citation>Yetmar ZA, Bhaimia E, Bierle DM, Ganesh R, Razonable RR. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy. Transpl Infect Dis. (2022) 24:e13779. doi: 10.1111/tid.13779</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13779</ArticleId><ArticleId IdType="pubmed">34932874</ArticleId></ArticleIdList></Reference><Reference><Citation>Anjan S, Natori Y, Fernandez Betances AA, Agritelley MS, Mattiazzi A, Arosemena L, et al. . Breakthrough COVID-19 infections after mRNA vaccination in solid organ transplant recipients in miami, florida. Transplantation. (2021) 105:e139–41. doi: 10.1097/TP.0000000000003902</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000003902</ArticleId><ArticleId IdType="pmc">PMC8487698</ArticleId><ArticleId IdType="pubmed">34319928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Zheng Q, Madhira V, Olex AL, Anzalone AJ, Vinson A, et al. . Association between immune dysfunction and COVID 19 breakthrough infection after SARS-CoV-2 vaccination in the US. JAMA Intern Med. (2022) 182:153–62. doi: 10.1001/jamainternmed.2021.7024</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.7024</ArticleId><ArticleId IdType="pmc">PMC8715386</ArticleId><ArticleId IdType="pubmed">34962505</ArticleId></ArticleIdList></Reference><Reference><Citation>Netti GS, Infante B, Troise D, Mercuri S, Panico M, Spadaccino F, et al. . mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients. Am J Transplant. (2022) 22:1475–82. doi: 10.1111/ajt.16958</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16958</ArticleId><ArticleId IdType="pmc">PMC9303518</ArticleId><ArticleId IdType="pubmed">35038362</ArticleId></ArticleIdList></Reference><Reference><Citation>Marion O, Del Bello A, Abravanel F, Couat C, Faguer S, Esposito L, et al. . Safety and immunogenicity of anti-SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants. Ann Intern Med. (2021) 174:1336–8. doi: 10.7326/M21-1341</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-1341</ArticleId><ArticleId IdType="pmc">PMC8252830</ArticleId><ArticleId IdType="pubmed">34029487</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamar N, Abravanel F, Marion O, Couat C, Izopet J, Del Bello A. Three doses of an mRNA covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. (2021) 385:661–2. doi: 10.1056/NEJMc2108861</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2108861</ArticleId><ArticleId IdType="pmc">PMC8262620</ArticleId><ArticleId IdType="pubmed">34161700</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. . Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. (2021) 325:2204–6. doi: 10.1001/jama.2021.7489</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7489</ArticleId><ArticleId IdType="pmc">PMC8100911</ArticleId><ArticleId IdType="pubmed">33950155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanis A, Haddadin Z, Spieker AJ, Waqfi D, Rankin DA, Talj R, et al. . Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls. Transpl Infect Dis. (2021) 24:e13772. doi: 10.1111/tid.13772</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13772</ArticleId><ArticleId IdType="pmc">PMC10795074</ArticleId><ArticleId IdType="pubmed">34905653</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Varela I, Len O, Villagrasa A, Marquez-Algaba E, Esperalba J, Dopazo C, et al. . Low seroprevalence of SARS-CoV-2 antibodies in a liver transplant cohort. Transpl Int. (2021) 34:1908–13. doi: 10.1111/tri.13946</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tri.13946</ArticleId><ArticleId IdType="pmc">PMC8420468</ArticleId><ArticleId IdType="pubmed">34121244</ArticleId></ArticleIdList></Reference><Reference><Citation>Cromer D, Steain M, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. . Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis. Lancet Microbe. (2022) 3:e52–61. doi: 10.1016/S2666-5247(21)00267-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00267-6</ArticleId><ArticleId IdType="pmc">PMC8592563</ArticleId><ArticleId IdType="pubmed">34806056</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury SD, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. . Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. (2021) 27:1205–11. doi: 10.1038/s41591-021-01377-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01377-8</ArticleId><ArticleId IdType="pubmed">34002089</ArticleId></ArticleIdList></Reference><Reference><Citation>Abebe EC, Dejenie TA. Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications. Front Immunol. (2023) 14:1055457. doi: 10.3389/fimmu.2023.1055457</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1055457</ArticleId><ArticleId IdType="pmc">PMC9892939</ArticleId><ArticleId IdType="pubmed">36742320</ArticleId></ArticleIdList></Reference><Reference><Citation>Painter MM, Johnston TS, Lundgreen KA, Santos JJS, Qin JS, Goel RR, et al. . Prior vaccination promotes early activation of memory T cells and enchances immune responses during SARS-CoV-2 breakthrough infection. Nat Immunol. (2023) 24:1711–24. doi: 10.1038/s41590-023-01613-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01613-y</ArticleId><ArticleId IdType="pubmed">37735592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaku CI, Bergeron AJ, Ahlm C, Normark J, Sakharkar M, Forsell MNE, et al. . Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection. Sci Immunol. (2022) 7:eabq3511. doi: 10.1126/sciimmunol.abq3511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abq3511</ArticleId><ArticleId IdType="pmc">PMC9097882</ArticleId><ArticleId IdType="pubmed">35549299</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokal A, Barba-Spaeth G, Hunault L, Fernandez I, Broketa M, Meola A, et al. . SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals. Immunity. (2023) 56:2137–51. doi: 10.1016/j.immuni.2023.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2023.07.007</ArticleId><ArticleId IdType="pubmed">37543032</ArticleId></ArticleIdList></Reference><Reference><Citation>Purtha WE, Tedder TF, Johnson S, Bhattacharya D, Diamond MS. Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med. (2011) 208:2599–606. doi: 10.1084/jem.20110740</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20110740</ArticleId><ArticleId IdType="pmc">PMC3244041</ArticleId><ArticleId IdType="pubmed">22162833</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel F, Shlomchik M. Memory B cells of mice and humans. Annu Rev Immunol. (2017) 35:255–84. doi: 10.1146/annurev-immunol-041015-055531</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-041015-055531</ArticleId><ArticleId IdType="pubmed">28142324</ArticleId></ArticleIdList></Reference><Reference><Citation>GeurtsvanKessel CH, Geers D, Schmitz KS, Mykytyn A, Lamers MM, Bogers S, et al. . Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients. Sci Immunol. (2022) 7:eabo2202. doi: 10.1126/sciimmunol.abo2202</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abo2202</ArticleId><ArticleId IdType="pmc">PMC8939771</ArticleId><ArticleId IdType="pubmed">35113647</ArticleId></ArticleIdList></Reference><Reference><Citation>Siedner MJ, Boucau J, Gilbert RF, Uddin R, Luu J, Haneuse S, et al. . Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections. JCI Insight. (2022) 7:e155483. doi: 10.1172/jci.insight.155483</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.155483</ArticleId><ArticleId IdType="pmc">PMC8855795</ArticleId><ArticleId IdType="pubmed">34871181</ArticleId></ArticleIdList></Reference><Reference><Citation>Favà A, Donadeu L, Sabe N, Pernin V, Gonzalez-Costello J, Llado L, et al. . SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients. Am J Transplant. (2021) 21:2749–61. doi: 10.1111/ajt.16570</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16570</ArticleId><ArticleId IdType="pmc">PMC8251492</ArticleId><ArticleId IdType="pubmed">33756051</ArticleId></ArticleIdList></Reference><Reference><Citation>Favà A, Donadeu L, Jouve T, Gonzalez-Costello J, Llado L, Santana C, et al. . A comprehensive assessment of long-term SARS-CoV-2-specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients. Kidney Int. (2022) 101:1027–38. doi: 10.1016/j.kint.2021.12.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2021.12.029</ArticleId><ArticleId IdType="pmc">PMC8813192</ArticleId><ArticleId IdType="pubmed">35124011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavaglio F, Frangipane V, Morosini M, Gabanti E, Zelini P, Sammartino JC, et al. . Robust and persistent B- and T-cell responses after COVID-19 in immunocompetent and solid organ transplant recipient patients. Viruses. (2021) 13:2261. doi: 10.3390/v13112261</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112261</ArticleId><ArticleId IdType="pmc">PMC8621286</ArticleId><ArticleId IdType="pubmed">34835067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattler A, Angermair S, Stockmann H, Moira Heim K, Khadzhynov D, Treskatsch S, et al. . SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition. J Clin Invest. (2020) 130:6477–89. doi: 10.1172/JCI140965</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140965</ArticleId><ArticleId IdType="pmc">PMC7685725</ArticleId><ArticleId IdType="pubmed">32833687</ArticleId></ArticleIdList></Reference><Reference><Citation>Charmetant X, Espi M, Barba T, Ovize A, Morelon E, Mathieu C, et al. . Predictive factors of a viral neutralizing humoral response after a third dose of COVID-19 mRNA vaccine. Am J Transplant. (2022) 22:1442–50. doi: 10.1111/ajt.16990</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16990</ArticleId><ArticleId IdType="pmc">PMC10149236</ArticleId><ArticleId IdType="pubmed">35114060</ArticleId></ArticleIdList></Reference><Reference><Citation>Rincon-Arevalo H, Choi M, Stefanski A, Halleck F, Weber U, Szelinski F, et al. . Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients. Sci Immunol. (2021) 6:eabj1031. doi: 10.1126/sciimmunol.abj1031</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abj1031</ArticleId><ArticleId IdType="pubmed">34131023</ArticleId></ArticleIdList></Reference><Reference><Citation>Kared H, Alirezaylavasani A, Persgard Lund K, Chopra A, Tietze L, de Matos Kasahara T, et al. . Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients. EBioMedicine. (2023) 97:104833. doi: 10.1016/j.ebiom.2023.104833</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104833</ArticleId><ArticleId IdType="pmc">PMC10585642</ArticleId><ArticleId IdType="pubmed">37844534</ArticleId></ArticleIdList></Reference><Reference><Citation>Halloran PF. Immunosupressive drugs for kidney transplantation. N Engl J Med. (2004) 351:2715–29. doi: 10.1056/NEJMra033540</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra033540</ArticleId><ArticleId IdType="pubmed">15616206</ArticleId></ArticleIdList></Reference><Reference><Citation>Willicombe M, Thomas D, McAdoo S. COVID-19 and calcineurin inhibitors: should they get left out in the storm? J Am Soc Nephrol. (2020) 31:1145–6. doi: 10.1681/ASN.2020030348</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020030348</ArticleId><ArticleId IdType="pmc">PMC7269341</ArticleId><ArticleId IdType="pubmed">32312797</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrezenmeier E, Rincon-Arevalo H, Jens A, Stefanski A, Hammett C, Osmanodja B, et al. . Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant patients. JCI Insight. (2022) 7:e157836. doi: 10.1172/jci.insight.157836</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.157836</ArticleId><ArticleId IdType="pmc">PMC9090237</ArticleId><ArticleId IdType="pubmed">35349490</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki K, Turner AP, Oliva Shaffer V, Gangappa S, Keller SA, Bachmann MF, et al. . mTOR regulates memory CD8 T-cell differentiation. Nature. (2009) 460:108–12. doi: 10.1038/nature08155</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08155</ArticleId><ArticleId IdType="pmc">PMC2710807</ArticleId><ArticleId IdType="pubmed">19543266</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, et al. . Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study. Am J Transplant. (2019) 19:3018–34. doi: 10.1111/ajt.15480</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.15480</ArticleId><ArticleId IdType="pubmed">31152476</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Living guidance for clinical management of COVID-19: Living Guidance (Accessed 23 November 2021).</Citation></Reference><Reference><Citation>Grau-Expósito J, Perea D, Suppi M, Massana N, Vergara A, Soler MJ, et al. . Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells. PLoS Pathog. (2022) 18:e1010171. doi: 10.1371/journal.ppat.1010171</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010171</ArticleId><ArticleId IdType="pmc">PMC8791477</ArticleId><ArticleId IdType="pubmed">35025963</ArticleId></ArticleIdList></Reference><Reference><Citation>Caillard S, Thaunat O, Benotmane I, Masset C, Blancho G. Antibody response to a fourth messenger RNA COVID-19 vaccine dose in kidney transplant recipients: A case series. Ann Intern Med. (2022) 175:455–6. doi: 10.7326/L21-0598</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/L21-0598</ArticleId><ArticleId IdType="pmc">PMC8754215</ArticleId><ArticleId IdType="pubmed">35007148</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling M, et al. . Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. (2021) 71:103561. doi: 10.1016/j.ebiom.2021.103561</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103561</ArticleId><ArticleId IdType="pmc">PMC8390300</ArticleId><ArticleId IdType="pubmed">34455390</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorovits B, Azadeh M, Buchlis G, Fiscella M, Harrison T, Havert M, et al. . Evaluation of cellular immune response to adeno-associated virus-based gene therapy. AAPS J. (2023) 25:47. doi: 10.1208/s12248-023-00814-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-023-00814-5</ArticleId><ArticleId IdType="pmc">PMC10132926</ArticleId><ArticleId IdType="pubmed">37101079</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland JM, Altman DGI. RCalculating correlation coefficients with repeated observations: Part 2—Correlation between subjects. BMJ. (1995) 310(6980):633. doi: 10.1136/bmj.310.6980.633</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.310.6980.633</ArticleId><ArticleId IdType="pmc">PMC2549010</ArticleId><ArticleId IdType="pubmed">7703752</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattler A, Schrezenmeier E, Weber UA, Potekhin A, Bachmann F, Straub/Hohenbleicher H, et al. . Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest. (2021) 131:e150175. doi: 10.1172/JCI150175</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI150175</ArticleId><ArticleId IdType="pmc">PMC8279581</ArticleId><ArticleId IdType="pubmed">34101623</ArticleId></ArticleIdList></Reference><Reference><Citation>Grupper A, Rabinowich L, Schwartz D, Schwartz IF, Ben-Yehoyada M, Shashar M, et al. . Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant. (2021) 21:2719–26. doi: 10.1111/ajt.16615</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16615</ArticleId><ArticleId IdType="pmc">PMC8250589</ArticleId><ArticleId IdType="pubmed">33866672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucchiari D, Egri N, Bodro M, Herrera S, Del Risco-Zevallos J, Casals-Urquiza J, et al. . Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients. Am J Transplant. (2021) 21:2727–39. doi: 10.1111/ajt.16701</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16701</ArticleId><ArticleId IdType="pmc">PMC8222867</ArticleId><ArticleId IdType="pubmed">34036720</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, et al. . Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. (2021) 325:1784–6. doi: 10.1001/jama.2021.4385</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.4385</ArticleId><ArticleId IdType="pmc">PMC7961463</ArticleId><ArticleId IdType="pubmed">33720292</ArticleId></ArticleIdList></Reference><Reference><Citation>Christophorou E, Nilsson AC, Petersen I, Lindvig SO, Davidsen JR, Abazi R, et al. . Humoral antibody response following mRNA vaccines against SARS-CoV-2 in solid organ transplant recipients; a status after a fifth and bivalent vaccine dose. Front Immunol. (2023) 14:1270814. doi: 10.3389/fimmu.2023.1270814</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1270814</ArticleId><ArticleId IdType="pmc">PMC10711048</ArticleId><ArticleId IdType="pubmed">38090591</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanrenterghem Y, van Hooff J, Squifflet J, Salmela K, Rigotti P, Jindal RM, et al. . Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant. (2005) 5:87–95. doi: 10.1111/j.1600-6143.2004.00638.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2004.00638.x</ArticleId><ArticleId IdType="pubmed">15636615</ArticleId></ArticleIdList></Reference><Reference><Citation>Asberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, et al. . Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial. Clin Transplant. (2013) 27:e151–6. doi: 10.1111/ctr.12076</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.12076</ArticleId><ArticleId IdType="pubmed">23351013</ArticleId></ArticleIdList></Reference><Reference><Citation>Baran DA, Zucker MJ, Arroyo LH, Camacho M, Goldschmidt ME, Nicholls SJ, et al. . A prospective, randomized trial of single-drug versus dual-drug immunosupression in heart transplantation. Circulation: Heart Failure. (2011) 4:129–37. doi: 10.1161/CIRCHEARTFAILURE.110.958520</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.110.958520</ArticleId><ArticleId IdType="pubmed">21216835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestard O, Meneghini M, Crespo E, Bemelman F, Koch M, Volk HD, et al. . Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial. Am J Transplant. (2021) 21:2833–45. doi: 10.1111/ajt.16563</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16563</ArticleId><ArticleId IdType="pubmed">33725408</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, et al. . Everolimus with reduced calcineurin inhibitor exposure in renal transplantation. J Am Soc Nephrol. (2018) 29:1979–91. doi: 10.1681/ASN.2018010009</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2018010009</ArticleId><ArticleId IdType="pmc">PMC6050928</ArticleId><ArticleId IdType="pubmed">29752413</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannick JB, del Fiudice F, Lattanzi M, Valiante NM, Praestgaard J, Huang B, et al. . mTOR inhibition improves immune function in the elderly. Sci Transl Med. (2014) 6:268ra179. doi: 10.1126/scitranslmed.3009892</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3009892</ArticleId><ArticleId IdType="pubmed">25540326</ArticleId></ArticleIdList></Reference><Reference><Citation>Pérez-Flores I, Juarez I, Aiffil Meneses AS, Lopez-Gomez A, Calvo Romero N, Rodriguez-Cubillo B, et al. . Role of mTOR inhibitor in the celular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients. Front Immunol. (2023) 14:1111569. doi: 10.3389/fimmu.2023.1111569</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1111569</ArticleId><ArticleId IdType="pmc">PMC9931894</ArticleId><ArticleId IdType="pubmed">36817489</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>